146 related articles for article (PubMed ID: 35777313)
1. Magnetic resonance imaging of dorsal root ganglion in a pre-symptomatic subject with familial amyloid polyneuropathy transthyretin E61K.
Murakami T; Watanabe H; Yamamoto A; Sunada Y
J Neurol Sci; 2022 Sep; 440():120329. PubMed ID: 35777313
[TBL] [Abstract][Full Text] [Related]
2. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y
J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin Amyloid Neuropathy: The Schwann Cell Hypothesis.
Murakami T; Sunada Y
Adv Exp Med Biol; 2019; 1190():371-378. PubMed ID: 31760657
[TBL] [Abstract][Full Text] [Related]
5. [Transthyretin familial amyloid polyneuropathy].
Kopishinskaya SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502
[TBL] [Abstract][Full Text] [Related]
6. Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic tools.
Kollmer J; Sahm F; Hegenbart U; Purrucker JC; Kimmich C; Schönland SO; Hund E; Heiland S; Hayes JM; Kristen AV; Röcken C; Pham M; Bendszus M; Weiler M
Neurology; 2017 Aug; 89(5):475-484. PubMed ID: 28679600
[TBL] [Abstract][Full Text] [Related]
7. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
Kollmer J; Hund E; Hornung B; Hegenbart U; Schönland SO; Kimmich C; Kristen AV; Purrucker J; Röcken C; Heiland S; Bendszus M; Pham M
Brain; 2015 Mar; 138(Pt 3):549-62. PubMed ID: 25526974
[TBL] [Abstract][Full Text] [Related]
9. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy.
Koike H; Misu K; Sugiura M; Iijima M; Mori K; Yamamoto M; Hattori N; Mukai E; Ando Y; Ikeda S; Sobue G
Neurology; 2004 Jul; 63(1):129-38. PubMed ID: 15249622
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin is not expressed by dorsal root ganglia cells.
Sousa MM; Saraiva MJ
Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560
[TBL] [Abstract][Full Text] [Related]
11. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Berg I; Thor S; Hammarström P
Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
[TBL] [Abstract][Full Text] [Related]
12. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915
[TBL] [Abstract][Full Text] [Related]
13. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
Lai HJ; Lai WT; Jin L; Kuo KT; Lee MJ
J Neurol Sci; 2020 Jun; 413():116810. PubMed ID: 32247966
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
Sousa MM; Saraiva MJ
Prog Neurobiol; 2003 Dec; 71(5):385-400. PubMed ID: 14757117
[TBL] [Abstract][Full Text] [Related]
16. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M
Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015
[TBL] [Abstract][Full Text] [Related]
18. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.
Escolano-Lozano F; Barreiros AP; Birklein F; Geber C
Brain Behav; 2018 Jan; 8(1):e00889. PubMed ID: 29568686
[TBL] [Abstract][Full Text] [Related]
20. Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review.
Martens B; De Pauw M; De Bleecker JL
Acta Neurol Belg; 2018 Jun; 118(2):179-185. PubMed ID: 29524093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
